0001209191-21-008655.txt : 20210208
0001209191-21-008655.hdr.sgml : 20210208
20210208205049
ACCESSION NUMBER: 0001209191-21-008655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210208
DATE AS OF CHANGE: 20210208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shameze Rampertab
CENTRAL INDEX KEY: 0001721810
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 21603489
MAIL ADDRESS:
STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP.
STREET 2: 3928 VARSITY DRIVE
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX, INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX INC.
DATE OF NAME CHANGE: 20131210
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-08
0
0000876378
TRANSENTERIX, INC.
TRXC
0001721810
Shameze Rampertab
635 DAVIS DRIVE
SUITE 300
MORRISVILLE
NC
27560
0
1
0
0
EVP, Chief Financial Officer
Stock Options
4.21
2021-02-08
4
A
0
73078
0.00
A
2028-02-08
Common Stock
73078
73078
D
Restricted Stock Units
0.00
2021-02-08
4
A
0
59112
0.00
A
Common Stock
59112
59112
D
Restricted Stock Units
0.00
2021-02-08
4
A
0
59112
0.00
A
Common Stock
59112
59112
D
Restricted Stock Units
0.00
2021-02-08
4
A
0
59200
0.00
A
Common Stock
59200
59200
D
Award subject to forfeiture if the Registrant's stockholders do not approve an increase in the number of shares available under the Plan at the Registrant's 2021 annual meeting of stockholders.
Vests one-third annually on each of February 4, 2022, 2023 and 2024, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement").
Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse on the RSUs in three equal installments of 19,704 on each of February 4, 2022, 2023 and 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement.
Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.
PRSU award with time-based vesting in three equal installments of 19,704 on each of February 4, 2022, 2023 and 2024, and performance-based vesting only if, designated corporate goals are met.
Represents a discretionary retention bonus. Forfeiture restrictions will lapse on the RSUs on February 4, 2022, as long as the Reporting Person remains in continuous service during the vesting period.
/s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab
2021-02-08